India · Delayed Price · Currency is INR Cohance Lifesciences Statistics
Total Valuation
BOM:543064 has a market cap or net worth of INR 177.13 billion. The enterprise value is 179.10 billion.
| Market Cap | 177.13B |
| Enterprise Value | 179.10B |
Important Dates
The last earnings date was Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 382.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 23.61% |
| Float | 137.96M |
Valuation Ratios
The trailing PE ratio is 166.74 and the forward PE ratio is 70.89.
| PE Ratio | 166.74 |
| Forward PE | 70.89 |
| PS Ratio | 8.27 |
| PB Ratio | 4.39 |
| P/TBV Ratio | 7.01 |
| P/FCF Ratio | 119.33 |
| P/OCF Ratio | 48.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 56.52, with an EV/FCF ratio of 120.65.
| EV / Earnings | 168.60 |
| EV / Sales | 8.36 |
| EV / EBITDA | 56.52 |
| EV / EBIT | 143.96 |
| EV / FCF | 120.65 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.26 |
| Debt / FCF | 2.70 |
| Interest Coverage | 3.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 17.67M |
| Profits Per Employee | 876,485 |
| Employee Count | 1,212 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543064 has paid 428.80 million in taxes.
| Income Tax | 428.80M |
| Effective Tax Rate | 42.28% |
Stock Price Statistics
The stock price has decreased by -48.28% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.28% |
| 50-Day Moving Average | 440.21 |
| 200-Day Moving Average | 439.00 |
| Relative Strength Index (RSI) | 58.00 |
| Average Volume (20 Days) | 263,692 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543064 had revenue of INR 21.42 billion and earned 1.06 billion in profits.
| Revenue | 21.42B |
| Gross Profit | 15.07B |
| Operating Income | 1.24B |
| Pretax Income | 1.01B |
| Net Income | 1.06B |
| EBITDA | 3.17B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 3.26 billion in cash and 4.00 billion in debt, with a net cash position of -745.10 million.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 4.00B |
| Net Cash | -745.10M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.34B |
| Book Value Per Share | 102.03 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 3.68 billion and capital expenditures -2.20 billion, giving a free cash flow of 1.48 billion.
| Operating Cash Flow | 3.68B |
| Capital Expenditures | -2.20B |
| Depreciation & Amortization | 1.92B |
| Net Borrowing | -1.13B |
| Free Cash Flow | 1.48B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.36%, with operating and profit margins of 5.81% and 4.96%.
| Gross Margin | 70.36% |
| Operating Margin | 5.81% |
| Pretax Margin | 4.74% |
| Profit Margin | 4.96% |
| EBITDA Margin | 14.80% |
| EBIT Margin | 5.81% |
| FCF Margin | 6.54% |
Dividends & Yields
BOM:543064 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.60% |
| FCF Yield | 0.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:543064 is 508.33, which is 9.89% higher than the current price. The consensus rating is "Hold".
| Price Target | 508.33 |
| Price Target Difference | 9.89% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 12.27% |
| EPS Growth Forecast (3Y) | 38.27% |
Stock Splits
The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Sep 25, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |